Increasing threat of Gram-negative bacteria

被引:61
作者
Waterer, GW [1 ]
Wunderink, RG
机构
[1] Univ Western Australia, Royal Perth Hosp, Dept Med, Perth, WA 6009, Australia
[2] Methodist Le Bonheur Healthcare, Memphis, TN USA
[3] Univ Tennessee, Memphis, TN USA
关键词
antibiotic resistance; ventilator-associated pneumonia; Gram-negative bacteria; nosocomial infection; Enterobacteriaceae; beta-lactamase; Pseudomonas aeruginosa; plasmids; Acinetobacter; efflux pumps;
D O I
10.1097/00003246-200104001-00004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The widespread use of broad-spectrum antibiotics has led to emergence of antibiotic-resistant strains of many Gram-negative organisms. This problem is particularly serious in critically ill patients, especially those with ventilator-associated pneumonia, Extensive antibiotic resistance has developed in Gram-negative bacteria, due both to innate resistance in some species and the fact that they are highly adept at acquiring antibiotic-resistant determinants from each other. Antibiotic resistance develops through the following three basic mechanisms: alteration of the drug target, prevention of drug access to the target (including actively removing the drug from the bacteria), and drug inactivation. Certain Gram-negative microorganisms are particular problems in the intensive care unit, including Pseudomonas aeruginosa, Acinetobacter spp,, Stenotrophomonas maltophilia, and the Enterobacteriaceae. The combination of an increasing population at risk, and the natural virulence and adaptability of Gramnegative bacteria guarantees that critical care physicians will face a persistent and increasing challenge from these pathogens.
引用
收藏
页码:N75 / N81
页数:7
相关论文
共 132 条
[1]   Trends in bacterial resistance to fluoroquinolones [J].
Acar, JF ;
Goldstein, FW .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S67-S73
[2]  
*AM THOR SOC, 1995, AM J RESP CRIT CARE, V53, P1711
[3]  
[Anonymous], WHO SCI WORKING GROU
[4]  
[Anonymous], JAMA
[5]  
*ASM TASK FORC, 1995, AM SOC MICR
[6]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[7]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[8]   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[9]  
Brewer Susan Crouch, 1996, Chest, V109, P1019, DOI 10.1378/chest.109.4.1019
[10]   Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin:: A multicenter, randomized controlled trial [J].
Brun-Buisson, C ;
Sollet, JP ;
Schweich, H ;
Brière, S ;
Petit, C .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :346-354